EP 1218015 A2 20020703 - PHARMACEUTICAL COMPOSITION OF NATEGLINIDE AND ANOTHER ANTIDIABETIC AGENT
Title (en)
PHARMACEUTICAL COMPOSITION OF NATEGLINIDE AND ANOTHER ANTIDIABETIC AGENT
Title (de)
ZUSAMMENSETZUNG WELCHE NATEGLINIDE AND EINE ANDERE ANTIDIABETISCHE VERBINDUNG ENTHÄLT
Title (fr)
PROCEDE DE TRAITEMENT DE TROUBLES DU METABOLISME
Publication
Application
Priority
- EP 0009816 W 20001006
- US 41530799 A 19991008
- US 41530899 A 19991008
Abstract (en)
[origin: WO0126639A2] The invention relates to a combination which comprises nateglinide and (a) an antidiabetic phenylacetic acid derivative or (b) acarbose for simultaneous, separate or sequential use, in particular in the treatment of diseases, especially metabolic disorders; to a method of prevention, delay of progression or treatment of metabolic disorders, more especially diabetes, or a disease or condition associated with diabetes, and to a method of improving the bodily appearance of a warm-blooded animal.
IPC 1-7
IPC 8 full level
A61K 31/445 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP)
A61K 31/195 (2013.01); A61K 31/445 (2013.01); A61K 31/702 (2013.01); A61K 31/715 (2013.01); A61K 45/06 (2013.01); A61P 3/00 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 0126639A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0126639 A2 20010419; WO 0126639 A3 20020110; AU 1133901 A 20010423; EP 1218015 A2 20020703
DOCDB simple family (application)
EP 0009816 W 20001006; AU 1133901 A 20001006; EP 00972695 A 20001006